New frontiers in transfusion biology: Identification and significance of mediators of morbidity and mortality in stored red blood cells

Transfusion

Volumn 51, Issue 4, 2011, Pages 874-880

  Grimshaw, Katie ^a   Sahler, Julie ^a   Spinelli, Sherry L ^a   Phipps, Richard P ^a   Blumberg, Neil ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

CLINICAL TRIAL; CONFERENCE PAPER; ENDOTHELIAL MICROPARTICLE; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; HUMAN; INFLAMMATION; MORBIDITY; MORTALITY; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOSIS;

BLOOD PLATELETS; BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS;

EID: 79954606146     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03095.x     Document Type: Conference Paper

References (62)

1. Health Care Cost and Utilization Project (HCUP). Facts and figures [monograph on the internet]. Rockville (MD): Agency for Healthcare Research and Quality; 2007. [cited 2010 Dec 21]. Available from: URL
2. Schrier SL, Sohmer PR, Moore GL, Ma L, Junga I,. Red blood cell membrane abnormalities during storage: correlation with in vivo survival. Transfusion 1982; 22: 261-5. (Pubitemid 12038765)
3. Popovsky MA, Moore SB,. Mechanism of transfusion-related acute lung injury. Blood 1991; 77: 2299.
4. Tartter PI, Quintero S, Barron DM,. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg 1986; 152: 479-82. (Pubitemid 17179143)
5. Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M,. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998; 176: 462-6. (Pubitemid 29021548)
6. van Hilten JA, van de Watering LM, van Bockel JH, van de Velde CJ, Kievit J, Brand R, van den Hout WB, Geelkerken RH, Roumen RM, Wesselink RM, Koopman-van Gemert AW, Koning J, Brand A,. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ 2004; 328: 1281-4. (Pubitemid 38703484)
7. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM,. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555-62. (Pubitemid 39314961)
8. Nilsson KR, Berenholtz SM, Garrett-Mayer E, Dorman T, Klag MJ, Pronovost PJ,. Association between venous thromboembolism and perioperative allogeneic transfusion. Arch Surg 2007; 142: 126-32. Discussion 33. (Pubitemid 46294131)
9. Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH,. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008; 168: 2377-81.
10. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, Harvey MS, Huysmans HA, Brand A,. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97: 562-8. (Pubitemid 28090685)
11. Blumberg N, Heal JM, Liesveld JL, Phillips GL, Rowe JM,. Platelet transfusion and survival in adults with acute leukemia. Leukemia 2008; 22: 631-5. (Pubitemid 351386735)
12. Blumberg N, Gettings KF, Turner C, Heal JM, Phipps RP,. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006; 46: 1813-21. (Pubitemid 44435735)
13. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC,. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108: 2455-62. (Pubitemid 44497533)
14. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber EC, O'Hara DA, Noveck H, Strom BL,. Perioperative blood transfusion and postoperative mortality. JAMA 1998; 279: 199-205. (Pubitemid 28133781)
15. Adams RJ, Brambilla DJ, Granger S, Gallagher D, Vichinsky E, Abboud MR, Pegelow CH, Woods G, Rohde EM, Nichols FT, Jones A, Luden JP, Bowman L, Hagner S, Morales KH, Roach ES,; STOP Study. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood 2004; 103: 3689-94. (Pubitemid 38596283)
16. Moroff G, Holme S, Keegan T, Heaton A,. Storage of ADSOL-preserved red cells at 2.5 and 5.5 degrees C: comparable retention of in vitro properties. Vox Sang 1990; 59: 136-9. (Pubitemid 20332868)
17. Bonaventura J,. Clinical implications of the loss of vasoactive nitric oxide during red blood cell storage. Proc Natl Acad Sci U S A 2007; 104: 19165-6.
18. Winterbourn CC,. Free-radical production and oxidative reactions of hemoglobin. Environ Health Perspect 1985; 64: 321-30. (Pubitemid 16135800)
19. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ,. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 1990; 87: 9383-7. (Pubitemid 120030630)
20. Yazdanbakhsh K,. Controlling the complement system for prevention of red cell destruction. Curr Opin Hematol 2005; 12: 117-22. (Pubitemid 40315695)
21. Usry RT, Moore GL, Manalo FW,. Morphology of stored, rejuvenated human erythrocytes. Vox Sang 1975; 28: 176-83.
22. Bosman GJ, Werre JM, Willekens FL, Novotnà VM,. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008; 18: 335-47.
23. Blumberg N,. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 2005; 45: 33S-9S. Discussion 9S-40S.
24. Tinmouth A, Fergusson D, Yee IC, Hébert PC,; ABLE Investigators; Canadian Critical Care Trials Group. Clinical consequences of red cell storage in the critically ill. Transfusion 2006; 46: 2014-27. (Pubitemid 44631611)
25. Gianotti L, Pyles T, Alexander JW, Babcock GF, Carey MA,. Impact of blood transfusion and burn injury on microbial translocation and bacterial survival. Transfusion 1992; 32: 312-7.
26. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E,. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17. (Pubitemid 29084771)
27. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, Eissner HJ, Schildberg FW,. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342: 1328-33. (Pubitemid 23345181)
28. Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, Brand R, van Oers MH, Brand A,. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004; 109: 2755-60. (Pubitemid 38744552)
29. Weinberg JA, McGwin G, Griffin RL, Huynh VQ, Cherry SA, Marques MB, Reiff DA, Kerby JD, Rue LW,. Age of transfused blood: an independent predictor of mortality despite universal leukoreduction. J Trauma 2008; 65: 279-82. Discussion 82-4.
30. Deans KJ, Minneci PC, Suffredini AF, Danner RL, Hoffman WD, Ciu X, Klein HG, Schechter AN, Banks SM, Eichacker PQ, Natanson C,. Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols. Crit Care Med 2007; 35: 1509-16. (Pubitemid 46809314)
31. Blumberg N, Zhao H, Wang H, Messing S, Heal JM, Lyman GH,. The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Transfusion 2007; 47: 573-81. (Pubitemid 46449617)
32. Blumberg N, Heal JM, Rowe JM,. A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disord 2004; 4: 6.
33. Spinella PC, Carroll CL, Staff I, Gross R, Mc Quay J, Keibel L, Wade CE, Holcomb JB,. Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in hospital mortality in patients with traumatic injuries. Crit Care 2009; 13: R151.
34. Phipps RP, Kaufman J, Blumberg N,. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001; 357: 2023-4. (Pubitemid 32592392)
35. Stack G, Snyder EL,. Cytokine generation in stored platelet concentrates. Transfusion 1994; 34: 20-5. (Pubitemid 24018760)
36. Davenport RD, Strieter RM, Standiford TJ, Kunkel SL,. Interleukin-8 production in red blood cell incompatibility. Blood 1990; 76: 2439-42.
37. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG,. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331: 625-8. (Pubitemid 24276861)
38. Blumberg N, Heal JM,. Transfusion immunomodulation. In:, Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD,. Blood banking and transfusion medicine. Philadelphia (PA): Churchill Livingstone Elsevier; 2007. p. 701-12.
39. Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP,. Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993; 81: 1880-2. (Pubitemid 23101603)
40. Davenport RD, Kunkel SL,. Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transfus Med Rev 1994; 8: 157-68. (Pubitemid 24221397)
41. Vo TD, Cowles J, Heal JM, Blumberg N,. Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions. Transfus Med 2001; 11: 45-7. (Pubitemid 32180321)
42. Gladwin MT, Vichinsky E,. Pulmonary complications of sickle cell disease. N Engl J Med 2008; 359: 2254-65.
43. Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ,. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 2007; 110: 2166-72. (Pubitemid 47443936)
44. Parker CJ,. Paroxysmal nocturnal hemoglobinuria: an historical overview. Hematology Am Soc Hematol Educ Program 2008; 93-103.
45. Telen MJ, Kaufman RE,. Part II: normal hematologic system, the mature erythrocyte. In:, Greer JP, Forerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B,. Wintrobe's clinical hematology. Philadelphia (PA): Lippincott Williams & Wilkins; 2004. p. 217-48.
46. Nishiyama T, Hirasaki A, Odaka Y, Iwasaki T, Kobayashi O, Seto K,. [Concentrations of haptoglobin and free hemoglobin in preserved whole blood]. Masui 1994; 43: 736-9. (Pubitemid 24167560)
47. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ,. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-203.
48. Praticà D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA,. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 1998; 4: 1189-92. (Pubitemid 28468835)
49. Yin K, Halushka PV, Yan YT, Wong PY,. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. J Pharmacol Exp Ther 1994; 270: 1192-6. (Pubitemid 24315239)
50. Diamant M, Tushuizen ME, Sturk A, Nieuwland R,. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34: 392-401. (Pubitemid 38859560)
51. Tissot JD, Rubin O, Canellini G,. Analysis and clinical relevance of microparticles from red blood cells. Curr Opin Hematol 2010; 17: 571-7.
52. Lawrie AS, Albanyan A, Cardigan RA, Mackie IJ, Harrison P,. Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang 2009; 96: 206-12.
53. Thomas S, Beard M, Garwood M, Callaert M, Cardigan R,. Platelet concentrates produced from whole blood using the Atreus processing system. Vox Sang 2009; 97: 93-101.
54. Xiong Z, Cavaretta J, Qu L, Stolz DB, Triulzi D, Lee JS,. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion 2011; 51: 610-21.
55. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A,. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101: 439-51.
56. Matheu FA, McFaul SJ,. Supernates from stored red blood cells inhibit platelet aggregation. Transfusion 2010; 50: 1196-202.
57. Silvain J, Pena A, Cayla G, Brieger D, Bellemain-Appaix A, Chastre T, Vignalou JB, Beygui F, Barthelemy O, Collet JP, Montalescot G,. Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study. Eur Heart J 2010; 31: 2816-21.
58. Vlaar AP, Hofstra JJ, Levi M, Kulik W, Nieuwland R, Tool AT, Schultz MJ, de Korte D, Juffermans NP,. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology 2010; 113: 92-103.
59. Blumberg N, Heal JM, Gettings KF, Phipps RP, Masel D, Refaai MA, Kirkley SA, Fialkow LB,. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010; 50: 2738-44.
60. Wagner DD, Burger PC,. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003; 23: 2131-7. (Pubitemid 37532311)
61. Aslam R, Speck ER, Kim M, Freedman J, Semple JW,. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells. Transfusion 2008; 48: 1778-86.
62. Bunn HF,. The use of hemoglobin as a blood substitute. Am J Hematol 1993; 42: 112-7. (Pubitemid 23008323)